ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALNY Alnylam Pharmaceuticals Inc

254.04
0.97 (0.38%)
Last Updated: 18:28:32
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 335.04M319.29M318.75M750.53M439.72M494.33M659.83M500.92M
Operating Income -188.61M-149.81M-229.83M213.87M-116.4M-43.44M48.61M-76.91M
Pre Tax Income -207.02M-172.36M-274.21M150.74M-137.69M-63.59M-11.17M-108.66M
Net Income -207.49M-174.1M-276.02M147.75M-137.87M-65.94M-16.89M-111.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -73.95M-153.32M-273.99M156.21M-136.76M-49.47M-15.6M-528.36M
EBITDA -174.3M-135.74M-216.65M227.2M-102.92M-29.92M63.62M-62.92M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 47.16M89.91M74.91M219.75M492.85M844.29M1.04B1.83B
Operating Income -424.59M-500.09M-814.67M-939.43M-828.44M-708.65M-785.07M-282.18M
Pre Tax Income -410.11M-490.87M-760.67M-885.25M-855.6M-852.14M-1.13B-433.52M
Net Income -410.11M-490.87M-761.5M-886.12M-858.28M-852.82M-1.13B-440.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -4.772-4.925-7.526-7.898-7.372-7.096-9.128-3.508
EBIT -418.42M-503.11M-789.94M-918.7M-782.91M-727.96M-791.28M-407.86M
EBITDA -414.99M-488.19M-801.87M-922.83M-798.24M-661.09M-740.6M-228.12M